Skip to main content

Find Clinical Trials

Home
Conditions
HIV Infections

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

1,675 public trials 170 recruiting studies

Refine in advanced search Browse all conditions

HIV Infections trial results

Completed

Improving Treatment Adherence in HIV-Infected Individuals

NCT00247611

Conditions: Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +16 more
Locations: University of Connecticut Health Center Farmington, Connecticut, United States

Hartford Hospital Hartford, Connecticut, United States

Yale-New Haven Hospital Nathan Smith Clinic New Haven, Connecticut, United States

Hospital of Saint Raphael New Haven, Connecticut, United States

View Trial Details

Completed

Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents

NCT01849393

Conditions: Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Behavior, +21 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women

NCT01812980

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +19 more
Locations: Nrf/Dst Vpd Rmpru Soweto, Gauteng, South Africa

View Trial Details

Completed

Case Management Alternatives for African American Women at High Risk for HIV

NCT00780260

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Nova Southeastern University Miami, Florida, United States

View Trial Details

Completed

Novel Therapy for Glucose Intolerance in HIV Disease

NCT02006914

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +18 more
Locations: Stony Brook University Hospital GCRC Stony Brook, New York, United States

View Trial Details

Completed

Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults

NCT00708110

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Bakersfield, California, United States

GSK Investigational Site Long Beach, California, United States

GSK Investigational Site Newport Beach, California, United States

GSK Investigational Site Northridge, California, United States

View all 18 locations

View Trial Details

Completed

A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients

NCT01199939

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Long Beach, California, United States

Los Angeles, California, United States

San Francisco, California, United States

Denver, Colorado, United States

View all 23 locations

View Trial Details

Completed

An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART

NCT01541085

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Adherence, Improvement Measure (AIM) System

NCT01252212

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Behavior, +19 more
Locations: Ward 86, San Francisco General Hospital San Francisco, California, United States

View Trial Details

Completed

A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)

NCT01102972

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Hobson City, Alabama, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Bakersfield, California, United States

View all 46 locations

View Trial Details